Drug Shortage Report for APO-AMOXI
Report ID | 162918 |
Drug Identification Number | 00628158 |
Brand name | APO-AMOXI |
Common or Proper name | AMOXICILLAN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | AMOXICILLIN |
Strength(s) | 250MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 100mL and 150mL |
ATC code | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-06-15 |
Estimated end date | 2023-10-13 |
Actual end date | 2023-10-05 |
Shortage status | Resolved |
Updated date | 2024-02-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v41 | 2024-02-14 | English | Compare |
v40 | 2023-10-06 | English | Compare |
v39 | 2023-09-28 | French | Compare |
v38 | 2023-09-28 | English | Compare |
v37 | 2023-07-27 | French | Compare |
v36 | 2023-07-27 | English | Compare |
v35 | 2023-06-23 | French | Compare |
v34 | 2023-06-23 | English | Compare |
v33 | 2023-05-26 | French | Compare |
v32 | 2023-05-26 | English | Compare |
v31 | 2023-04-06 | French | Compare |
v30 | 2023-04-06 | English | Compare |
v29 | 2023-02-16 | French | Compare |
v28 | 2023-02-16 | English | Compare |
v27 | 2023-01-06 | French | Compare |
v26 | 2023-01-06 | English | Compare |
v25 | 2022-12-03 | French | Compare |
v24 | 2022-12-03 | English | Compare |
v23 | 2022-11-18 | English | Compare |
v22 | 2022-11-18 | English | Compare |